Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1673
    +0.0016 (+0.14%)
     

  • GBP/USD

    1.2499
    -0.0012 (-0.10%)
     

  • Bitcoin GBP

    51,211.15
    -395.93 (-0.77%)
     

  • CMC Crypto 200

    1,332.59
    -63.95 (-4.58%)
     

  • S&P 500

    5,106.33
    +57.91 (+1.15%)
     

  • DOW

    38,299.96
    +214.16 (+0.56%)
     

  • CRUDE OIL

    83.68
    +0.11 (+0.13%)
     

  • GOLD FUTURES

    2,352.10
    +9.60 (+0.41%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Smith & Nephew's first-quarter trading profit dips

Reuters - UK Focus

LONDON, May 1 (Reuters) - Smith & Nephew (LSE: SN.L - news) , Europe's largest maker of artificial joints, posted a 5 percent drop in underlying trading profit on Thursday, after some U.S. patients pulled their procedures into the previous quarter.

The company posted trading profit of $229 million on revenue of $1.07 billion, up 1 percent on an underlying basis, both narrowly missing average analyst forecasts.

Chief Executive Olivier Bohuon said the group remained confident in its 2014 outlook as it roll-outs new products and sees an increasing contribution from acquisitions.

Smith & Nephew faces a stronger competitor in Zimmer Holdings Inc, which agreed to buy rival Biomet Inc last week for more than $13 billion.

ADVERTISEMENT

The deal makes it the second-ranking orthopaedics company behind Johnson & Johnson (NYSE: JNJ - news) . Smith & Nephew will be fourth, trailing Stryker (Berlin: SYK.BE - news) .

Analysts said consolidation in the $45 billion global orthopaedics market had been a long time coming.

(Reporting by Paul Sandle; editing by Kate Holton)